Nebula Research & Development LLC Has $106,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Nebula Research & Development LLC reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 76.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,360 shares of the pharmacy operator's stock after selling 35,989 shares during the period. Nebula Research & Development LLC's holdings in Walgreens Boots Alliance were worth $106,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter valued at about $28,000. Finally, Independence Bank of Kentucky acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $39,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on WBA. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a research note on Monday. They set a "hold" rating on the stock. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Up 0.2 %

Shares of WBA stock traded up $0.02 during trading hours on Monday, hitting $11.00. 5,885,054 shares of the company were exchanged, compared to its average volume of 21,037,607. The company has a market capitalization of $9.51 billion, a PE ratio of -1.07, a PEG ratio of 1.31 and a beta of 0.77. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83. The business has a 50 day moving average of $10.97 and a two-hundred day moving average of $10.26.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.20 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of the stock in a transaction dated Sunday, April 27th. The stock was bought at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the acquisition, the chairman now owns 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This represents a 0.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 17.50% of the stock is currently owned by corporate insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.